Orforglipron Explained: A New Oral GLP-1 for Weight Loss
About this episode
This episode discusses orforglipron, a new oral GLP-1 for weight loss, comparing it to oral semaglutide in various aspects.
New oral GLP-1s are changing the weight loss game. Here is what you need to know before recommending or dispensing one. In this episode, TRC Healthcare Associate Editor and Clinical Pharmacist Vickie Danaher, PharmD, discusses how orforglipron, the second oral GLP-1 agonist for weight loss, stacks up against oral semaglutide in terms of dosing, efficacy, safety, and more. This is an excerpt from our May 2026 Pharmacy Essential Updates continuing education webinar series. 🏷️ Use code cc1026 at...
More episodes of Clinical Capsules - Actionable Medication Pearls in Minutes
- Navigating the Medicare GLP-1 Bridge: What Pharmacy Teams Need to Know
- Help Patients Use Continuous Glucose Monitors Safely and Effectively
Explore listener stats, chart rankings, contacts and more on the Clinical Capsules - Actionable Medication Pearls in Minutes podcast page.